ubiquitine

Ubiquitin is a small regulatory protein that tags other proteins to modulate their fate in the cell. In humans it comprises 76 amino acids, has a molecular weight of about 8.5 kDa, and is highly conserved across eukaryotes. Ubiquitin exists both in a free pool and covalently attached to substrate proteins, where it can influence stability, localization, or activity.

Protein ubiquitination occurs through a cascade of enzymes: an E1 activating enzyme, an E2 conjugating enzyme, and an E3 ligase that provides substrate specificity. A substrate can receive a single ubiquitin (monoubiquitination) or be modified by polyubiquitin chains. Ubiquitin contains seven lysine residues and an N-terminal methionine, allowing formation of diverse linkage types that encode different cellular signals. The K48-linked chain is the canonical signal directing proteins to degradation by the 26S proteasome, while other linkages, such as K63, participate in signaling, DNA repair, and endocytosis.

Deubiquitinating enzymes (DUBs) reverse ubiquitination by removing ubiquitin and editing chain architecture, thereby regulating the duration and outcome of ubiquitin signals. Beyond proteasomal degradation, ubiquitination controls numerous processes including DNA damage response, transcription, cell cycle progression, receptor trafficking, and autophagy.

Genetically, ubiquitin is encoded by several genes in humans (UBB, UBC, UBA52, and RPS27A). Some loci produce polyubiquitin precursors that are processed into individual ubiquitin units. The ubiquitin system is evolutionarily conserved and essential for cellular homeostasis; its dysfunction is linked to neurodegenerative diseases, cancer, and immune disorders.

Therapeutically, targeting the ubiquitin–proteasome system, notably proteasome inhibitors, is an established cancer treatment strategy. Ongoing research continues to elucidate the full range of ubiquitin signals and their roles in health and disease.